The FDA wants to ban a common ingredient in over-the-counter cold and allergy medications
Pharmacy over the counter cold and flu medicine, NyQuil, DayQuil, Mucinex.The U.S. Food and Drug Administration (FDA) ...
These Cold and Flu Medicines Contain Phenylephrine, the Ingredient the FDA Plans to Ban
Phenylephrine is a medication that’s been used to relieve nasal congestion caused by colds, allergies, and hay fever, per the ...
pharmaphorum3d
Pfizer rounds out haemophilia portfolio with FDA approval
Pfizer’s anti-TFPI antibody marstacimab has been approved by the FDA to treat haemophilia ... administered as a flat dose – i.e., not determined by weight, which simplifies administration ...
pharmaphorum2d
CD20 market heats up as FDA OKs AbbVie, Genmab bispecific
Micrograph of a diffuse large B cell lymphoma, AbbVie and partner Genmab have FDA approval for the lead drug ... for “relapsed or refractory DLBCL, not otherwise specified (NOS), including ...
Medscape6d
ISMP Updates its List of Drug Name Pairs with TALL Man Letters
Resources used to select the drug name pairs targeted for tall man letters included the ISMP list of name pairs with recommended tall man letters (63%), the FDA-approved list of name pairs with ...
US FDA declines full approval for Intercept's liver disease drug
The U.S. Food and Drug Administration on Tuesday declined full approval for Intercept Pharmaceuticals' liver disease drug, ...
FiercePharma2d
FDA rejects Intercept's ask for Ocaliva full nod in rare liver disease, but accelerated approval remains
In the wake of an unfavorable advisory committee meeting in September, Intercept Pharmaceuticals’ bid to win full approval ...
MedPage Today2d
FDA Rejects Full Approval of Liver Disease Drug
Opens in a new tab or window The FDA declined to grant full approval to obeticholic acid (Ocaliva ... which agreed that the ...
medtechdive3h
FDA breakthrough device decisions rebound after recent declines
The FDA designated 166 products under its breakthrough devices program in its most recent financial year, reversing the ...
FDA Wants to Ban Popular but Ineffective Cold Remedy Ingredient
The agency made the proposal after finding that the ingredient, known as oral phenylephrine, doesn’t relieve stuffy noses.
news.bloomberglaw5d
Teva Urges Appeals Judges to Restore Inhaler Patents on FDA List
Teva Pharmaceutical Industries Ltd. argued Friday the Federal Circuit should reverse a district judge’s too-narrow interpretation of the statutory definition for “drug” adopted when striking five of ...